Sg Americas Securities, LLC Syros Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.02 - $3.8 $12,252 - $45,645	-12,012 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$3.26 - $4.66 $62,213 - $88,931	-19,084 Reduced 61.37%	12,012 $39,000
Q3 2021 Nov 01, 2021	BUY	$4.08 - $5.66 $126,871 - $176,003	31,096 New	31,096 $139,000
Q2 2021 Aug 12, 2021	SELL	$5.01 - $7.48 $82,715 - $123,494	-16,510 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.19 - $14.95 $118,706 - $246,824	16,510 New	16,510 $123,000
Q3 2020 Nov 09, 2020	SELL	$8.69 - $14.47 $196,602 - $327,369	-22,624 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$5.21 - $11.03 $45,597 - $96,534	8,752 Added 63.09%	22,624 $241,000
Q1 2020 Apr 30, 2020	BUY	$4.46 - $9.2 $61,869 - $127,622	13,872 New	13,872 $82,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.